<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03962244</url>
  </required_header>
  <id_info>
    <org_study_id>19-1201</org_study_id>
    <nct_id>NCT03962244</nct_id>
  </id_info>
  <brief_title>Stent Therapy Versus Endoscopic Vacuum Therapy for Anastomotic Leaks After Esophagectomy</brief_title>
  <acronym>EsoLeak</acronym>
  <official_title>Endoscopic Management of ESOphago-gastric Anastomotic LEAKages (EsoLeak): Stent Therapy Versus Endoscopic Vacuum Therapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital of Cologne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Universitätsklinikum Hamburg-Eppendorf</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital of Cologne</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Exploratory study of the efficiency of endoscopic stenting versus endoscopic vacuum therapy
      in patients with intrathoracic esophago-gastric anastomotic leakage after oncological
      resection of the esophagus.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      We analyze the outcome of using self-expanding metal stents (SEMS) and endoscopic vacuum
      therapy (EVT) in the treatment of postoperative leakage after esophagogastrostomy.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 1, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Satisfaction of treatment assessed by EORTC QLQ - OES18</measure>
    <time_frame>6 months</time_frame>
    <description>Assessing the quality of life of patients during the treatment of stent and EVT with a questionnaire by EORTC QLQ - OES18. This Questionnaire was developed to assess the quality of life of cancer patients.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Leaks, Anastomotic</condition>
  <arm_group>
    <arm_group_label>SEMS Group</arm_group_label>
    <description>The outcome of using self-expanding metal stents (SEMS) in the treatment of postoperative leakage after esophagogastrostomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>EVT Group</arm_group_label>
    <description>The outcome of using endoscopic vacuum therapy (EVT) in the treatment of postoperative leakage after esophagogastrostomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>EsoSponge</intervention_name>
    <description>Endoscopically placed an EsoSponge for Negative pressure wound therapy in the area of the esophagogastric anastomotic leaks</description>
    <arm_group_label>EVT Group</arm_group_label>
    <other_name>Negative pressure wound therapy</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Self-Expanding Metal Stent</intervention_name>
    <description>Endoscopically placed self-expanding-metal-stent (SEMS) for negative pressure wound therapy in the area of the esophagogastric anastomotic leaks</description>
    <arm_group_label>SEMS Group</arm_group_label>
    <other_name>SEMS, stent</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patient with an intrathoracic esophago-gastric anastomotic leak after oncologic
        esophagectomy (Ivor-Lewis).
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Histologically confirmed oesophageal carcinoma or similarly operated neoplasia (e.g.,
             GIST, NET, subepithelial tumors)

          -  Esophagectomy with an intrathoracic esophago-gastric anastomosis

          -  Radiologically or endoscopically diagnosed esophago-gastric anastomotic leakage

          -  Clinical symptoms / symptoms due to insufficiency or increase in signs of
             inflammation, most likely as a result of anastomotic leakage

          -  Age ≥18 years

          -  To empower the patient to understand the scope of the study and its consequences or
             information, to consent to it and to sign the educational documents.

          -  Written declaration of consent of the patient to be included. If the patient is unable
             to sign by hand, a witness must confirm the oral examination by signature.

        Exclusion Criteria:

          -  Macroscopically incompletely resected tumor (R2), palliative resection

          -  Endoscopically verified necrosis or critical ischemia of the anastomotic region of the
             interponate

          -  Size of insufficiency more than 50% of circumference

          -  Impossibility of radiological interventional insertion of a drainage

          -  Early anastomotic leak (≤ 48 hours postoperatively), late insufficiencies (&gt; 4 weeks)

          -  Therapeutic anticoagulation

          -  Severe septic shock that indicates surgical therapy

          -  Pregnant and lactating women
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Seung-Hun Chon, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital of Cologne</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Michael Tachezy, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universitätsklinikum Hamburg-Eppendorf (UKE)</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Seung-Hun Chon, MD</last_name>
    <phone>+49221478 4864</phone>
    <email>seung-hun.chon@uk-koeln.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Christiane Bruns, MD</last_name>
    <phone>0049221 478 4801</phone>
    <email>Christiane.bruns@uk-koeln.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Hospital of Cologne</name>
      <address>
        <city>Cologne</city>
        <state>NRW</state>
        <zip>50937</zip>
        <country>Germany</country>
      </address>
    </facility>
    <contact>
      <last_name>SeungHun Chon, MD</last_name>
      <phone>+49 221 478 4864</phone>
      <email>seung-hun.chon@uk-koeln.de</email>
    </contact>
    <investigator>
      <last_name>Seung-Hun Chon, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Hamburg-Eppendorf (UKE)</name>
      <address>
        <city>Hamburg</city>
        <country>Germany</country>
      </address>
    </facility>
    <contact>
      <last_name>Michael Tachezy, MD</last_name>
      <email>mtachezy@uke.de</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <results_reference>
    <citation>Bartella I, Mallmann C, Bürger M, Toex U, Goeser T, Bruns C, Chon SH. Stent-over-sponge (SOS): a rescue option in patients with complex postoperative anastomotic leaks after esophagectomy. Endoscopy. 2019 Aug;51(8):E227-E228. doi: 10.1055/a-0885-9659. Epub 2019 May 2.</citation>
    <PMID>31049889</PMID>
  </results_reference>
  <results_reference>
    <citation>Berlth F, Bludau M, Plum PS, Herbold T, Christ H, Alakus H, Kleinert R, Bruns CJ, Hölscher AH, Chon SH. Self-Expanding Metal Stents Versus Endoscopic Vacuum Therapy in Anastomotic Leak Treatment After Oncologic Gastroesophageal Surgery. J Gastrointest Surg. 2019 Jan;23(1):67-75. doi: 10.1007/s11605-018-4000-x. Epub 2018 Oct 29.</citation>
    <PMID>30374816</PMID>
  </results_reference>
  <results_reference>
    <citation>Grimminger PP, Goense L, Gockel I, Bergeat D, Bertheuil N, Chandramohan SM, Chen KN, Chon SH, Denis C, Goh KL, Gronnier C, Liu JF, Meunier B, Nafteux P, Pirchi ED, Schiesser M, Thieme R, Wu A, Wu PC, Buttar N, Chang AC. Diagnosis, assessment, and management of surgical complications following esophagectomy. Ann N Y Acad Sci. 2018 Dec;1434(1):254-273. doi: 10.1111/nyas.13920. Epub 2018 Jul 8. Review.</citation>
    <PMID>29984413</PMID>
  </results_reference>
  <results_reference>
    <citation>Chon SH, Toex U, Plum PS, Fuchs C, Kleinert R, Bruns C, Goeser T. Successful closure of a gastropulmonary fistula after esophagectomy using the Apollo Overstitch and endoscopic vacuum therapy. Endoscopy. 2018 Jul;50(7):E149-E150. doi: 10.1055/a-0592-6384. Epub 2018 Apr 13.</citation>
    <PMID>29653446</PMID>
  </results_reference>
  <results_reference>
    <citation>Bludau M, Fuchs HF, Herbold T, Maus MKH, Alakus H, Popp F, Leers JM, Bruns CJ, Hölscher AH, Schröder W, Chon SH. Results of endoscopic vacuum-assisted closure device for treatment of upper GI leaks. Surg Endosc. 2018 Apr;32(4):1906-1914. doi: 10.1007/s00464-017-5883-4. Epub 2017 Dec 7.</citation>
    <PMID>29218673</PMID>
  </results_reference>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>May 21, 2019</study_first_submitted>
  <study_first_submitted_qc>May 22, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 23, 2019</study_first_posted>
  <last_update_submitted>March 23, 2020</last_update_submitted>
  <last_update_submitted_qc>March 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 24, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital of Cologne</investigator_affiliation>
    <investigator_full_name>Seung-Hun Chon</investigator_full_name>
    <investigator_title>PI</investigator_title>
  </responsible_party>
  <keyword>Esophagectomy, Esophageal Cancer, Vacuum therapy, Stents</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anastomotic Leak</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

